Nektar Therapeutics (NKTR) EBT Margin (2010 - 2026)
Nektar Therapeutics' EBT Margin came in at -397.80% for Q2 2026, down 45.27 percentage points from -352.53% a year earlier and down 1.06 percentage points from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) EBT Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Nektar Therapeutics reported EBT Margin of -280.49%, down 125.94 percentage points year-over-year; for FY2025, it came in at -281.52%, down 160.41 percentage points from FY2024.
- EBT Margin carries a five-year change of +8.81 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -121.10% in FY2024 (+185.43 pp), -306.54% in FY2023 (+89.95 pp), -396.48% in FY2022 (+117.00 pp) and -513.49% in FY2021 (-223.17 pp).
- The Q2 2026 figure represents the lowest quarterly EBT Margin since Q1 2025.
- Year-over-year, EBT Margin increased in three of the last eight quarters, with an average year-over-year change of -61.42 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q2 2023 (a gain of 486.86 percentage points), and the weakest in Q2 2022 (a drop of 294.67 percentage points).
- Business Quant data shows NKTR's EBT Margin at -396.74% (Q1 2026), -159.13% (Q4 2025) and -297.04% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - | -397.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -397.80% |
| Mar 31, 2026 | -396.74% |
| Dec 31, 2025 | -159.13% |
| Sep 30, 2025 | -297.04% |
| Jun 30, 2025 | -352.53% |
| Mar 31, 2025 | -443.30% |
| Dec 31, 2024 | 24.00% |
| Sep 30, 2024 | -153.57% |
| Jun 30, 2024 | -222.73% |
| Mar 31, 2024 | -170.23% |
| Dec 31, 2023 | -176.29% |
| Sep 30, 2023 | -190.10% |
| Jun 30, 2023 | -249.62% |
| Mar 31, 2023 | -634.81% |
| Dec 31, 2022 | -256.75% |
| Sep 30, 2022 | -250.60% |
| Jun 30, 2022 | -736.47% |
| Mar 31, 2022 | -363.66% |
| Dec 31, 2021 | -582.39% |
| Sep 30, 2021 | -520.02% |
API Access
Nektar Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();